Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025)

Regeneron Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $300000.0 for Q4 2025.

• In Q4 2025, Acquisitions fell 97.39% year-over-year to $300000.0; the TTM figure through Dec 2025 stood at $14.8 million (down 77.71% YoY), while the FY2025 annual figure was $3.3 million, down 80.0% from the prior year.
• Acquisitions was $300000.0 for Q4 2025 at Regeneron Pharmaceuticals, down from $3.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $51.1 million in Q3 2023 to a low of $300000.0 in Q4 2025.
• Historically, Acquisitions has averaged $13.9 million across 3 years, with a median of $3.8 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Acquisitions surged 202.63% in 2024, then plunged 97.39% in 2025.
• A 3-year view of Acquisitions shows it stood at $3.8 million in 2023, then soared by 202.63% to $11.5 million in 2024, then slumped by 97.39% to $300000.0 in 2025.
• The last three Acquisitions figures came in at $300000.0 (Q4 2025), $3.0 million (Q3 2025), and $11.5 million (Q4 2024), per Business Quant data.